← Browse by Condition
Medical Condition
nsclc non small cell lung cancer
Total Trials
6
Recruiting Now
6
Trial Phases
Phase 2, Phase 1, Phase 1, Phase 2
NCT06967532
Recruiting
Efficacy of Torque Teno Virus as a Biomarker for Predicting Treatment Response of Immune Checkpoint Inhibitor Therapy and Postoperative Outcome in NSCLC Patients
Enrollment
90 pts
Location
Austria
Sponsor
Medical University of Vienna
NCT06667167 Phase 2
Recruiting
First Line Therapy for Extensive SCLC Patients, Treated with Chemo+Keytruda Followed by Keytuda+Trodelvy
Enrollment
21 pts
Location
Israel
Sponsor
Nir Peled
NCT07327489
Recruiting
Predicting Response to Immunotherapy From Analysis of Live Tumor Biopsies
Enrollment
2,000 pts
Location
United States
Sponsor
Elephas
NCT06253871 Phase 1
Recruiting
A Phase 1/1b Study of IAM1363 in HER2 Cancers
Enrollment
243 pts
Location
United States, Franc...
Sponsor
Iambic Therapeutics, Inc
NCT04585750 Phase 1, Phase 2
Recruiting
The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)
Enrollment
300 pts
Location
United States, Austr...
Sponsor
PMV Pharmaceuticals, Inc
NCT05873686 Phase 1
Recruiting
A Phase 1 Clinical Study of NXP900 in Subjects With Advanced Cancers
Enrollment
140 pts
Location
United States, Unite...
Sponsor
Nuvectis Pharma, Inc.